east-large-B.png
 

10.16.19

The Deal Meeting will bring together the most experienced deal-makers and business development executives in life sciences for an exclusive and invite-only meeting in a first-class and off-the-record setting.

deal-meeting-background.jpg

SPONSORS

 
 
 
 
 

SPONSORSHIP OPPORTUNITIES

Sponsors gain access in an intimate and private setting with life science industry top leaders and decision makers.

For additional information, please contact Susan Grayson at susan@crushlifesicences.com or sponsor@crushlifesciences.com.

October 16, 2019 PRELIMINARY AGENDA

8:00 – 8:45 am                          
Registration and Networking Breakfast

8:45 – 9:00 am                          
Welcome and Opening Remarks

9:00 - 10:30 am
KEYNOTE SPEAKER
Guhan Subramanian, Author, Negotiauctions: New Dealmaking Strategies for a Competitive Marketplace,
is the Joseph Flom Professor of Law and Business at the Harvard Law School and the Douglas Weaver Professor of Business Law at the Harvard Business School.  He is the first person in the history of Harvard University to hold tenured appointments at both HLS and HBS.  At HLS he teaches courses in negotiations and corporate law.  At HBS he teaches in several executive education programs, such as Strategic Negotiations, Making Corporate Boards More Effective, and the Advanced Management Program. He is the faculty chair for the JD/MBA program at Harvard University, the Harvard Program on Negotiation, and the Mergers & Acquisitions executive education course at HBS.  Prior to joining the Harvard faculty he spent three years at McKinsey & Company.
See full bio: hls.harvard.edu/faculty/directory/10868/Subramanian

10:30 - 11:00 am
Networking Break

11:00 - 11:45 am
The
Makings of M&A: Tactics and Strategies of The Deal
Deals don’t just happen, they are made. And the skills to make them are the most critical aspect—and take talent and diligence from all parties involved. M&A is a well-choreographed dance among CEOs and bankers. A valuable company or asset will only take you so far, and the devil in the details has to be considered and well managed.  From creating demand and then holding out for the best offer, knowing what to say to whom and when will lead you to the best deal. This session will offer insights from experienced dealmakers.
John Cox, former CEO, Bioverativ; Barbara Fox, former CEO, Tilos Therapeutics; Steve Sands, Vice Chairman Investment Banking and Chairman Global Healthcare Group, Lazard
Moderator: Rachael Bushey, Partner & Chair of Life Sciences, Pepper Hamilton, LLP

11:45 - 12:30 pm
All in The Family: The Role and Impact of Family Office Investing on Life Sciences
With the rise of venture creation firms and a shift in the capital market landscape, companies are increasingly turning to family offices as an alternative source of capital. At the same time, many family offices are looking to life science companies for investment opportunities. They especially can be a great source of capital during early raises, but finding them means getting the right introductions and then being prepared to pitch to their interest, establish trust, and maintain the relationship for the future. Find out how to start your search, manage the challenges presented by some inexperienced but well-meaning investors, and work with the savvy ones by hearing insights directly from experts on both sides the deals.
Dharminder Chahal, Investment Manager, Van Herk Investments & CEO, SkylineDx

12:30 - 1:30 pm
Networking Lunch

  

 

 

1:30 - 2:15 pm
Highway to Healthcare: How AI is Going to Change the Life Science Industry
Artificial Intelligence and machine learning are increasingly being incorporated into healthcare and life sciences. But let’s turn down the buzz and talk about the practicalities. From imaging to drug development, these technologies have the potential to greatly impact and transform the industry, or to be a set of shiny objects that add little value at the next inflection. Hear about the latest in AI and how it may impact your business—including your ability to conduct deals—in the future.
Arnaub Chatterjee, Senior Vice President-Product and Ecosystem, Acorn AI, Medidata Solutions; Neil Tenenholtz, Senior Research Engineer, Microsoft Research

2:15 - 2:45 pm
Fireside Chat

2:45 - 3:00 pm
Networking Break

3:00 - 3:45 pm
More Money, More Problems? Capital Efficiency vs Mega Millions
With venture investors trending towards company creation, some early stage companies may find it more difficult to raise $10 million vs the $100 million mega rounds seen recently. Yet with great capital comes great responsibility. Generating a return on each of those investments comes with unique challenges, including allocating it to necessary vs potentially non-value added activities. We juxtapose capital efficient models with large financings and the impact on business models and return profiles.
John Evans, CEO, Beam Therapeutics; Neil Exter, Partner, Third Rock Ventures; Wes Kapinen, President and CEO, Palvella Therapeutics; Peter Wirth, Venture Partner, Quan Capital

3:45 - 4:30 pm
Deep Dive: How A Complete Commercial Assessment Can Impact Your Deal
A commercial assessment is an essential part of any deal. Yet today’s diligence moves beyond just the science. From a changing payor landscape to new trends in patient dynamics, the depth of and timing of that assessment can greatly impact your transaction terms, and often the need for it is recognized and responded to is later than ideal. Build the due diligence package that delivers. 
Melissa Bradford-Klug, CEO, Mayfield Pharma; Phil McGurk, Head of East Coast Business Development & Acquisitions, AbbVie

4:30 - 5:00 pm
CRUSHed It” Deals of the Year Awards

5:00 - 6:00 pm
Networking Cocktail Reception

 

crush-background.jpg

October 3, 2018 - KEYNOTE SPEAKERS

Stuart Diamond Author Photo (003).jpg
 

Stuart Diamond

Stuart Diamond is one of the world’s leading experts on negotiation. His book, Getting More, has sold 1.5 million copies in 26 languages. Professor Diamond’s negotiation course at the top-rated Wharton School of Business has been the most sought-after there over 20 years. Google has adopted his new model as its primary method to train employees in negotiation worldwide; more than 12,000 have been trained with estimated additional revenues of $6 billion. The Wall Street Journal’s career site named Getting More the #1 book to read for your career. The book has been a New York Times best-seller and #1 U.S. business best-seller as listed by The Wall Street Journal and USA Today. Business Insider said Getting More is one of the 25 success books to read in one's life. Inc. Magazine said it is the best book on negotiation ever written.

Prof. Diamond has a law degree from Harvard and an MBA from Wharton. He was Associate Director of the Harvard Negotiation Project at Harvard Law School and headed its outside consulting firm, Conflict Management.

In a prior career, Professor Diamond was a journalist at The New York Times, where he won a Pulitzer Prize as part of a team investigating the crash of the Space Shuttle Columbia in 1986. He has taught and advised corporate and government leaders in more than 60 countries. This includes putting together the largest foreign-sourced commercial financing in the history of Ukraine, and persuading 3,000 farmers in the Bolivian jungles to forsake coca for bananas. He has been chairman of a high-tech company, co-owned an airline and served as an executive in a medical service business and a Wall Street energy futures trading firm. His many clients have included Microsoft, Facebook, Twitter, Morgan Stanley, Johnson & Johnson, General Electric, Prudential, the Government of Colombia and Educational Testing Service. He has advised executives and managers from more than 220 of the Fortune 500 companies, as well as numerous entrepreneurial firms and organizations, and has also taught at Harvard, Oxford, Columbia, NYU, USC, Berkeley and Penn Law.

Since early 2012, Professor Diamond has trained more than 5,000 Special Operations Forces (SOF), the U.S. military elite, as well as other military, on finding better ways to negotiate both internally and externally. The training has included Green Berets, Special Forces, Navy SEALs and various advisors for SOF in both the intelligence and operations areas. Getting More was one of 15 books recommended for the Special Ops Community by the Commander, U.S. Special Operations Command.

Professor Diamond’s work has included covering the nuclear accidents at Chernobyl and Three Mile Island, the Bhopal gas leak accident in India and OPEC in Europe and South America. His advice and training has spanned business and government officials in Saudi Arabia, Jordan and Kuwait; the President’s offices of Bolivia and Nicaragua; a manufacturing conglomerate in China, a billion-dollar enterprise in Russia and science and technology companies in Germany, Kazakhstan and Australia. His new negotiation process, which keys on collaboration, perceptions and emotions instead of power, leverage and logic, is credited with solving the 2008 Writers Strike in Hollywood, a multibillion dollar electronic trading rights dispute among commodity exchanges on Wall Street, and a $300 million technology merger.

Prof. Diamond is an expert in cross-cultural negotiation and diversity and has advised on the subject to the United Nations, World Bank and many companies. He has written 3 books, 2 documentary films and more than 2,000 articles, including dozens of page 1 of The New York Times. He has appeared on Today, Good Morning America, Fox News and other TV programs to address issues ranging from energy to environment to technology to trade. His articles have also appeared in The Washington Post and include subjects such as leadership and the problems of negotiating in a global environment amid continual change. His more than 40,000 students have ranged from country leaders to school children and disciplines from sales to mergers and acquisitions, technology, law, medicine, politics, the arts, labor-management and virtually every other major discipline.